Search Results
Showing results 1-11 of 79 for 'Women'
Showing results 1-11 of 79 for 'Women'
Prof. Yardena Samuels, who comes to Weizmann from the National Human Genome Research Institute, uses DNA sequencing to identify new genetic mutations involved in melanoma. She has already made progress by identifying a mutation – found in nearly one-fifth of melanoma cases – in a gene that is already targeted by an approved drug.
/news-media/news-releases/looking-for-the-genes-that-drive-cancer
Prof. Irit Sagi's innovative methods of studying dynamic enzymes are leading to new ways of designing medicines—including for cancer, autoimmune disorders, and multiple sclerosis.
/news-media/feature-stories/developing-the-next-generation-of-drugs
October is National Breast Cancer Awareness Month. Read about some of the groundbreaking research taking place at the Weizmann Institute to combat this all-too-common disease.
/news-media/feature-stories/what-the-weizmann-institute-is-doing-to-fight-breast-cancer
Triple-negative breast cancer is particularly hard to treat because, as its name suggests, it lacks three receptors that usually serve as targets for anti-cancer drugs. Now, Prof. Sima Lev has identified a promising new combination therapy that not only inhibits tumor growth and survival, but gets around the problem of drug-induced resistance.
/news-media/news-releases/double-whammy-for-triple-negative-breast-cancer
Dr. Karina Yaniv is investigating how blood and lymphatic vessels form during embryonic development. Her research could lead to novel treatments for heart disease, stroke, cancer, and other illnesses.
/news-media/feature-stories/the-origins-of-blood-and-lymphatic-vessels-and-the-hope-for-new-therapies
Prof. Ada Yonath believed that the ribosome was crucial and must be studied - despite the fact that the world's best labs had given up trying to do so. She pursued her idea over decades, and was the first scientist to crystallize the ribosome, later deciphering its structure—and, in 2009, she became the fourth woman in history to win the Nobel Prize in Chemistry.
/news-media/feature-stories/to-understand-the-principles-of-life-the-journey-of-prof-ada-yonath-from-ribosomes-to-the-nobel-prize
The summer before she entered college, Dr. Shari-Lynn Odzer spent a month on the Institute's campus as part of the Bessie F. Lawrence International Summer Science Institute (ISSI). More than three decades later, her daughter Jamie followed in her footsteps.
/news-media/feature-stories/a-mother-and-daughters-weizmann-journey-shari-lynn-and-jamie-odzer
Prof. Daniella Goldfarb addresses the ongoing need to have more women scientists in high-level scientific careers – and how the Institute's National Postdoctoral Award Program for Advancing Women in Science is helping make this happen. Also speaking to this issue are (in order of appearance): Prof. Nirit Dudovich, Dr. Michal Rivlin, Dr. Michal Sharon, Prof. Varda Rotter, and Dr. Noam Stern-Ginossar.
/news-media/video-gallery/weizmann-women-in-science-the-national-postdoctoral-award-program-for-advancing-women-in-science
Prof. Hadassa Degani's MRI-based Three Time Point (3TP) technology can detect and diagnose breast and other cancers without invasive and painful procedures.
/news-media/feature-stories/without-a-scalpel-accurate-breast-cancer-diagnosis-through-mri
2017 marks a decade since the Weizmann Institute took action to bridge science's gender gap by establishing the Israel National Postdoctoral Award Program for Advancing Women in Science. The program's success is quantifiable and inspirational – and good for women, for science, for the Weizmann Institute, for Israel … for the world.
/news-media/feature-stories/advancing-women-advancing-science